Recombinant LAG3 (Relatlimab Biosimilar) antibody

Catalog No. ABIN7597942

The Human Monoclonal anti-LAG3 (Relatlimab Biosimilar) antibody has been validated for . It is suitable to detect LAG3 (Relatlimab Biosimilar) in samples from Human.

Quick Overview for Recombinant LAG3 (Relatlimab Biosimilar) antibody (ABIN7597942)

Target: LAG3 (Relatlimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This LAG3 (Relatlimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-LAG3 (Relatlimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Relatlimab Biosimilar Antibody

Specificity: FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 7.5 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for LAG3 (Relatlimab Biosimilar)

Target: LAG3 (Relatlimab Biosimilar)

Alternative Name: Relatlimab Biosimilar

Target Type: Biosimilar

Background: FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3

UniProt: P18627

CAS-No: 1673516-98-7